NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

7669Listed tickers in the SEC universe 1972Issuers with current reporting periods 451Issuers with both EPS and ROE metrics 2026-09-21Fundamentals evaluated as of

Example screens

Period 1M3M6M1Y5YMAX
Drawing LineCandles

Example lists from a senior trader

Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

222 companies match

Showing 101–150 of 222 · page 3/5

Per page 2550100

Companies with a published price series: 222 of 222 · Daily EOD closes from the BibaMoney price store (splits reflected, cash dividends not) · 2026-09-21

FFIV NASDAQ

F5, INC.

432.03 +246.62% MAX
Combined rank
64.9
EPS acceleration
7.4 pp
ROE
18.8%
CAL NYSE

CALERES INC

11.74 -53.58% MAX
Combined rank
64.7
EPS acceleration
655.0 pp
ROE
7.8%
FLS NYSE

FLOWSERVE CORP

73.88 +63.56% MAX
Combined rank
64.7
EPS acceleration
9.9 pp
ROE
16.4%
CKX NYSE

CKX LANDS, INC.

11.26 +2.36% MAX
Combined rank
64.5
EPS acceleration
25.0 pp
ROE
13.5%
BROS NYSE

Dutch Bros Inc.

40.03 -7.59% MAX
Combined rank
63.6
EPS acceleration
40.0 pp
ROE
11.6%
DOV NYSE

DOVER Corp

187.42 +234.74% MAX
Combined rank
61.6
EPS acceleration
9.1 pp
ROE
14.7%
DDOG NASDAQ

Datadog, Inc.

229.92 +578.03% MAX
Combined rank
58.3
EPS acceleration
985.7 pp
ROE
4.1%
BCPC NASDAQ

BALCHEM CORP

167.05 +115.46% MAX
Combined rank
56.8
EPS acceleration
8.2 pp
ROE
12.6%
EML NASDAQ

EASTERN CO

25.59 +27.82% MAX
Combined rank
56.0
EPS acceleration
133.5 pp
ROE
6.2%
CVS NYSE

CVS HEALTH Corp

88.84 -7.21% MAX
Combined rank
55.6
EPS acceleration
125.6 pp
ROE
6.1%
CG NASDAQ

Carlyle Group Inc.

40.10 +157.55% MAX
Combined rank
54.6
EPS acceleration
148.2 pp
ROE
5.0%

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-09-18. Source: FRED / Federal Reserve.